000 05032naa a22006377i 4500
001 UMUN-OA-20261005-MLS-055
003 local
005 20261005174905.0
006 m o d
007 cr||||||||||||
008 261005s2019 xx o u000 0 eng d
024 7 _a10.1128/cmr.00032-18
_2doi
035 _a(local)EuropePMC:PMC6589859
040 _alocal
_beng
_clocal
041 0 _aeng
100 0 _aColleen S Kraft
_eauthor.
245 1 2 _aA Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of Clostridioides ( Clostridium ) difficile in Adults. /
_cColleen S Kraft; J Scott Parrott; Nancy E Cornish [and others].
264 1 _a[Place of publication not identified] :
_bAmerican Society for Microbiology (ASM),
_c2019.
300 _a1 online resource (1 article).
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
500 _aThe source lists 24 contributors; the first 12 names are recorded as access points. The complete source author list is retained in the catalogue manifest.
500 _aPublication type: Review article.
500 _aLinked open-access copy: published version.
506 0 _aOpen access; no subscription required for the linked open-access version.
_fUnrestricted online access
_2star
520 3 _aThe evidence base for the optimal laboratory diagnosis of Clostridioides ( Clostridium ) difficile in adults is currently unresolved due to the uncertain performance characteristics and various combinations of tests. This systematic review evaluates the diagnostic accuracy of laboratory testing algorithms that include nucleic acid amplification tests (NAATs) to detect the presence of C. difficile The systematic review and meta-analysis included eligible studies (those that had PICO [population, intervention, comparison, outcome] elements) that assessed the diagnostic accuracy of NAAT alone or following glutamate dehydrogenase (GDH) enzyme immunoassays (EIAs) or GDH EIAs plus C. difficile toxin EIAs (toxin). The diagnostic yield of NAAT for repeat testing after an initial negative result was also assessed. Two hundred thirty-eight studies met inclusion criteria. Seventy-two of these studies had sufficient data for meta-analysis. The strength of evidence ranged from high to insufficient. The uses of NAAT only, GDH-positive EIA followed by NAAT, and GDH-positive/toxin-negative EIA followed by NAAT are all recommended as American Society for Microbiology (ASM) best practices for the detection of the C. difficile toxin gene or organism. Meta-analysis of published evidence supports the use of testing algorithms that use NAAT alone or in combination with GDH or GDH plus toxin EIA to detect the presence of C. difficile in adults. There is insufficient evidence to recommend against repeat testing of the sample using NAAT after an initial negative result due to a lack of evidence of harm (i.e., financial, length of stay, or delay of treatment) as specified by the Laboratory Medicine Best Practices (LMBP) systematic review method in making such an assessment. Findings from this systematic review provide clarity to diagnostic testing strategies and highlight gaps, such as low numbers of GDH/toxin/PCR studies, in existing evidence on diagnostic performance, which can be used to guide future clinical research studies.
540 _aCreative Commons Attribution. See the linked licence for the applicable terms.
_uhttps://creativecommons.org/licenses/by/4.0/
546 _aIn English.
588 0 _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source.
590 _aCourse allocation: B. Sc. Medical Laboratory Science.
650 4 _aMeta-analysis
650 4 _aSystematic review
650 4 _aLaboratory Diagnosis
650 4 _aDiagnostic Accuracy
650 4 _aC. Difficile Infection
653 _aB. Sc. Medical Laboratory Science
653 _aUMUN open access collection
653 _aclinical chemistry
655 4 _aReview articles.
700 0 _aJ Scott Parrott
_eauthor.
700 0 _aNancy E Cornish
_eauthor.
700 0 _aMatthew L Rubinstein
_eauthor.
700 0 _aAlice S Weissfeld
_eauthor.
700 0 _aPeggy McNult
_eauthor.
700 0 _aIrving Nachamkin
_eauthor.
700 0 _aRomney M Humphries
_eauthor.
700 0 _aThomas J Kirn
_eauthor.
700 0 _aJennifer Dien Bard
_eauthor.
700 0 _aJoseph D Lutgring
_eauthor.
700 0 _aJonathan C Gullett
_eauthor.
773 0 _tClinical microbiology reviews
_gVol. 32, no. 3, (2019), pages/article e00032-18
_x0893-8512
856 4 0 _uhttps://europepmc.org/articles/PMC6589859
_yRead open-access publication
_zOpen access.
_70
884 _aCourse selection and automated MARC21 enrichment from Europe PMC metadata.
_g20261005
_khttps://europepmc.org/articles/PMC6589859
_qlocal
942 _n0
999 _c1197
_d1197